Sun Pharmaceutical beats profit forecasts but shares fall as costs weigh on margins
India's largest drugmaker navigates tension between specialty drug growth and rising research expenditure
India's largest drugmaker navigates tension between specialty drug growth and rising research expenditure
Bank sets $80 price target on biotech trading at $28.84, citing potential in underserved pulmonary market
Indian drugmaker bucks sector weakness as domestic revival offsets US headwinds faced by peers
Rocket Pharmaceuticals, the US gene therapy specialist, has bought itself an additional two years of operational runway through the $180mn sale of a regulatory voucher, easing pressure on a balance sheet that had been narrowing as the New…
Jazz Pharmaceuticals, the Dublin-headquartered drugmaker, has delivered a markedly stronger first-quarter performance than analysts had anticipated, capping a twelve-month period in which the stock has more than doubled — and prompting a…
Brano Therapeutics raised $6.8 million in seed financing to support the development of new therapies targeting heart failure, including Heart Failure with preserved Ejection Fraction (HFpEF), an area where treatment options remain limited.
Zealand Pharma shares climbed after the company reported positive clinical progress across its obesity pipeline and strengthened its financial outlook with expected milestone payments from partner Roche.
Neimeth International Pharmaceuticals, one of Nigeria's longest-established drugmakers, posted strong revenue growth in the first quarter of 2026, continuing a turnaround that has lifted the Lagos-listed group out of three years of losses…
Analysts have cut their earnings forecasts for Fine Foods & Pharmaceuticals N.T.M., the Italian contract development and manufacturing group, after a first-quarter result that came in broadly in line with expectations but failed to prevent…
For a company that not so long ago was the most valuable in Europe, Novo Nordisk has spent the past year looking unusually mortal. Its share price has shed 30% over twelve months. Its forecasts have been cut. Its American arch-rival, Eli…
Faron Pharmaceuticals, the Finnish clinical-stage immunotherapy group, has terminated its liquidity provision agreement with Lago Kapital, citing improved natural trading activity in its shares — a notable signal of the dual-listed…
Jazz Pharmaceuticals will report first-quarter results after the US market closes on Tuesday, with investors weighing the Dublin-headquartered drugmaker's recent commercial trajectory against the buoyant tone struck by larger…